This HTML5 document contains 146 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n12	http://dx.doi.org/10.1093/ANNONC/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q39647813

rdf:type

wikibase:Item

schema:description

wissenschaftlicher Artikel artículo científico publicado en 2012 научни чланак 2012年论文 teaduslik artikkel artikull shkencor სამეცნიერო სტატია 2012年論文 scientific article published on 23 February 2012 научна статия artigo científico vetenskaplig artikel articol științific наукова стаття, опублікована в лютому 2012 مقالة علمية نشرت في 23 فبراير 2012 мақолаи илмӣ 2012年論文 wetenschappelijk artikel επιστημονικό άρθρο vitskapeleg artikkel article scientifique 2012年论文 bài báo khoa học научни чланак 2012年论文 artigo científico artículu científicu espublizáu en 2012 videnskabelig artikel 2012年論文 บทความทางวิทยาศาสตร์ vědecký článek tieteellinen artikkeli vedecký článok מאמר מדעי bilimsel makale article scientific articolo scientifico 2012年の論文 scientific article published on 23 February 2012 2012년 논문 artikulong pang-agham 2012年论文 2012年論文 научная статья artigo científico article científic tudományos cikk 2012年論文 artikel ilmiah 2012年论文 naučni članak 2012 nî lūn-bûn artykuł naukowy scienca artikolo scientific article published on 23 February 2012 vitenskapelig artikkel ২৩ ফেব্রুয়ারি ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年论文

p:P577

wds:Q39647813-ADB3F3B4-A357-4078-BC17-37543611B330

wdt:P577

2012-02-23T00:00:00Z

p:P407

wds:Q39647813-F70AFB50-1D9A-40BE-AA85-CEFB02DBE531

wdt:P407

wd:Q1860

p:P2860

wds:Q39647813-87933BD9-2DEC-43B3-839F-D9997ADD4D07 wds:Q39647813-97E42639-E2D4-4D78-88FD-B5045ECF1B06 wds:Q39647813-76DD1D63-E59A-4A3F-A96B-1FF20C679780 wds:Q39647813-779B791E-19F1-4330-B55D-3F7D6DF80710 wds:Q39647813-8139A5C6-7DE9-4987-9555-69A96394398D wds:Q39647813-C18B2BB3-BF72-450A-8A28-C7D93AD25E02 wds:Q39647813-A1317DCD-A794-4A0E-BB7D-D683FFDA0C40 wds:Q39647813-18C5C7A8-385D-4204-BF63-4FB98D0D7F9F wds:Q39647813-2B365B59-DB71-47E9-BB31-0BA8A46C14DF wds:Q39647813-11538726-2936-4D85-8F11-E34DBB3DD2C3 wds:Q39647813-1319F061-A43D-45A2-A27F-DFD47FE981BE wds:Q39647813-4CCB8349-8340-44C2-B936-CF6355FAE4A6 wds:Q39647813-2CC9DF1D-6783-4A97-BA79-B559F3FF8BA9 wds:Q39647813-2F13CD42-FBAC-48E3-A4C6-4281E110F23D wds:Q39647813-31D6A7F0-C428-42EA-A0A0-AD0A6A7ED3F9 wds:Q39647813-37C48F5D-3C61-4945-9D34-0DB363BFE1A9 wds:Q39647813-0642CDD0-EE65-4BDD-88B1-11B15503C519 wds:Q39647813-068E1342-020E-4048-A359-784EB4BD5FEF wds:Q39647813-E46ED460-004F-43A5-82E4-9D3356B2C738 wds:Q39647813-FE8FABF9-D57E-42BA-A554-5D7C1079903C

wdt:P2860

wd:Q37680374 wd:Q43005729 wd:Q33760399 wd:Q48480509 wd:Q33250432 wd:Q53496139 wd:Q29619653 wd:Q39820471 wd:Q27851407 wd:Q37866791 wd:Q27860904 wd:Q34618537 wd:Q34576456 wd:Q46891324 wd:Q37100603 wd:Q27824811 wd:Q28271324 wd:Q33392786 wd:Q46488823 wd:Q43158528

p:P2093

wds:Q39647813-18705369-A769-44BB-AB43-41336392A3F4 wds:Q39647813-98082E29-C208-44EC-A2F2-F9CAD3D54A06 wds:Q39647813-8C0043F0-D17B-47BE-A779-69F7B29E4DA0 wds:Q39647813-A9D5D3C8-949E-4544-B7CE-DCF9AE43ED51 wds:Q39647813-AA260B8F-576D-43FF-BBC5-AE32BD033324

wdt:P2093

A Jakobsen L H Jensen T F Hansen J Ploen J Lindebjerg

rdfs:label

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

skos:prefLabel

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

schema:name

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

p:P1476

wds:Q39647813-A9D0A821-AF62-46EA-9F3C-610AAFF24271

wdt:P1476

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

p:P304

wds:Q39647813-3C279F05-71A1-4FC7-84B1-71B91E963247

wdt:P304

2341-2346

p:P31

wds:Q39647813-48FEB8A4-9A81-428C-AF1E-74ADAEF85CFC

wdt:P31

wd:Q13442814

p:P921

wds:Q39647813-980D1AE0-F71A-4D19-803D-46AA2CD126AB wds:Q39647813-81BF78C1-CD97-4952-AF19-3563623FA30B

wdt:P921

wd:Q974135 wd:Q42824440

p:P698

wds:Q39647813-242E00EB-B5B3-41B5-9FF2-885A93D4698D

wdtn:P698

n10:22367707

wdt:P698

22367707

p:P1433

wds:Q39647813-131364CB-04C7-435F-BD24-BD522B2D58E9

wdt:P1433

wd:Q326122

p:P433

wds:Q39647813-644D09BC-58D9-42F9-BDE0-185DBD41B1AA

p:P478

wds:Q39647813-AED7969A-BB11-4E9F-BD1C-944ACA98E4A1

wdt:P433

9

wdt:P478

23

p:P356

wds:Q39647813-21C25FB1-2022-4E21-9249-E56F5833B1B8

wdtn:P356

n12:MDS008

wdt:P356

10.1093/ANNONC/MDS008

p:P5875

wds:Q39647813-0F7033F6-56BC-4F7D-8FC0-1D172D8A84B3

wdt:P5875

221863996